结缔组织病相关间质性肺病的诊治进展

被引：34

作者：

王凯

殷松楼

机构：

[1] 徐州医科大学附属医院风湿免疫科

来源：

中国免疫学杂志 | 2016年 / 32卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R563 [肺疾病]; R593.2 [自身免疫性疾病、结缔组织疾病];

学科分类号：

100201 [内科学];

摘要：

<正>间质性肺病(Interstitial lung disease,ILD)是一组以不同程度肺泡炎及肺纤维化为基本病理改变的异质性非肿瘤和肺部感染性疾病的总称,按有无病因可分为特发性间质性肺病和继发性间质性肺病。继发性间质性肺病可继发于多种疾病、某些药物及石棉、粉尘、射线等。其中结缔组织病是继发性间质性肺病的重要病因之一。结缔组织病(Connective tissue disease,CTD)是以一类以血管和结缔组织的慢性炎症为病理基础而引起全身各器官损害的自身免疫性疾病。由于肺含有丰富的胶原、血管等结缔

引用

页码：1562 / 1565+1569 +1569

页数：5

共 22 条

[1]

类风湿关节炎合并肺间质疾病患者临床特点 [J].

宋良月 ;

左大辰 ;

张榕 ;

肖卫国 .

中华临床免疫和变态反应杂志, 2015, 9 (02) :85-90

[2]

原发性干燥综合征肺脏受累及其危险因素分析 [J].

高辉 ;

何菁 ;

张学武 ;

张霞 ;

冯敏 ;

陈丽君 ;

安媛 ;

李玉慧 ;

杨月 ;

陈雷 ;

张森 ;

刘冬舟 ;

栗占国 .

中华风湿病学杂志, 2015, (05)

[3]

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis [J].

Udwadia, Zarir F. ;

Mullerpattan, Jai B. ;

Balakrishnan, Canchi ;

Richeldi, Luca .

LUNG INDIA, 2015, 32 (01) :50-52

[4]

Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders [J].

Iudici, Michele ;

Cuomo, Giovanna ;

Vettori, Serena ;

Bocchino, Marialuisa ;

Zamparelli, Alessandro Sanduzzi ;

Cappabianca, Salvatore ;

Valentini, Gabriele .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (04) :437-444

[5]

Biomarkers of Rheumatoid Arthritis–Associated Interstitial Lung Disease<link href="#art38904-note-0001"/>.[J].Juan Chen;Tracy J. Doyle;Yongliang Liu;Rohit Aggarwal;Xiaoping Wang;Yonghong Shi;Sheng Xiang Ge;Heqing Huang;Qingyan Lin;Wen Liu;Yongjin Cai;Diane Koontz;Carl R. Fuhrman;Maria F. Golzarri;Yushi Liu;Hiroto Hatabu;Mizuki Nishino;Tetsuro Araki;Paul F. Dellaripa;Chester V. Oddis;Ivan O. Rosas;Dana P. Ascherman.Arthritis & Rheumatology.2015, 1

[6]

Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review [J].

Ge, Yongpeng ;

Peng, Qinglin ;

Zhang, Sigong ;

Zhou, Hang ;

Lu, Xin ;

Wang, Guochun .

CLINICAL RHEUMATOLOGY, 2015, 34 (01) :99-105

[7]

Survival and quality of life in rheumatoid arthritis–associated interstitial lung disease after lung transplantation.[J].Arash Yazdani;Lianne G. Singer;Vibeke Strand;Allan C. Gelber;Laura Williams;Shikha Mittoo.Journal of Heart and Lung Transplantation.2014, 5

[8]

Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus [J].

Sumida, Hayakazu ;

Asano, Yoshihide ;

Tamaki, Zenshiro ;

Aozasa, Naohiko ;

Taniguchi, Takashi ;

Takahashi, Takehiro ;

Toyama, Tetsuo ;

Ichimura, Yohei ;

Noda, Shinji ;

Akamata, Kaname ;

Miyazaki, Miki ;

Kuwano, Yoshihiro ;

Yanaba, Koichi ;

Sato, Shinichi .

JOURNAL OF DERMATOLOGY, 2014, 41 (05) :418-420

[9]

Rituximab in severe, treatment-refractory interstitial lung disease [J].

Keir, Gregory J. ;

Maher, Toby M. ;

Ming, Damien ;

Abdullah, Reza ;

de Lauretis, Angelo ;

Wickremasinghe, M. ;

Nicholson, Andrew G. ;

Hansell, David M. ;

Wells, Athol U. ;

Renzoni, Elisabetta A. .

RESPIROLOGY, 2014, 19 (03) :353-359

[10]

Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature [J].

Linda Nalotto ;

Luca Iaccarino ;

Margherita Zen ;

Mariele Gatto ;

Elisabetta Borella ;

Marta Domenighetti ;

Leonardo Punzi ;

Andrea Doria .

Immunologic Research, 2013, 56 :362-370

← 1 2 3 →